Listen on the go
CORRECT!
Next question
touchINFECTIOUS DISEASES touchINFECTIOUS DISEASES
    • FILTER YOUR SEARCH
    Content Type:
    Speciality:
    More Specialities
    Conference:
    More Conferences

    • Respiratory Infections

    Tuberculosis

    Respiratory Infections Content

    Respiratory Infections
    More than Baby Steps: Preventing Respiratory Syncytial Virus in Infants
    Jessica Huston, Eric F Egelund

    touchREVIEWS in Infectious Diseases. 2024;3(1):Online ahead of journal publication

    Respiratory syncytial virus (RSV) is often of increased concern in the autumn and winter months, especially for women who are pregnant, or those with newborns.1 Worldwide, RSV is the second leading cause of death (second to malaria) in children during their first year of life.2 Elderly people (>60 years of age) are also at an increased risk […]

    COVID-19, Vaccines, Viral Infections, Respiratory Infections
    Watch Time: 67 mins
    touchTALKS
    COVID-19 vaccination: What have we learned and what more can we do to address vaccine inequity in Africa and the Middle East?
    CE/CME ACCREDITED Dr Adidja Amani, Prof. Nada Melhem Translations available:

    Watch experts in infectious diseases discuss the issue of vaccine inequity in COVID-19 vaccination in Africa and the Middle East.

    Learning objectives
    Learning Objectives
    • Discuss the role of HCWs in addressing vaccine equity issues in Africa and the Middle East
    • Recall the key safety and efficacy data for COVID-19 vaccines
    • Summarize best practice for sharing information on vaccine effectiveness with the public in Africa and the Middle East
    • Explain the need for higher vaccine uptake and the implications of not achieving this, locally and globally
    COVID-19, Vaccines, Respiratory Infections
    Watch Time: 32 mins
    touchEXPERT OPINIONS
    The mRNA vaccine platform: A novel tool for the rapid development of vaccines against respiratory viral infections
    CE/CME ACCREDITED Dr Anna Blakney, Prof. Dr. med. Oliver Cornely, Prof. Ann R Falsey Translations available:

    Leading experts explore mRNA vaccine platforms for respiratory viruses, including their design, clinical application and future prospects.

    Learning objectives
    Learning Objectives
    • Recognize the rationale for mRNA-based vaccines and considerations for their design
    • Discuss the effectiveness of mRNA-based vaccines to manage respiratory viral diseases based on clinical and real-world experiences with COVID-19 vaccines
    • Discuss recent developments in the use of the mRNA platform to develop prophylactic and therapeutic vaccines for respiratory diseases
    COVID-19, Vaccines, Viral Infections, Respiratory Infections
    Watch Time: 37 mins
    touchIN CONVERSATION
    Practical considerations for COVID-19 vaccination in the Middle East
    CE/CME ACCREDITED Dr Farhan Fazal, Dr Nada Melhem Translations available:

    Watch experts in infectious diseases discuss COVID-19 vaccination challenges and strategies for improving vaccine uptake in the Middle East.

    Learning objectives
    Learning Objectives
    • Outline the benefits and risks associated with COVID-19 vaccines
    • Identify reasons for low COVID-19 vaccine uptake in the Middle East
    • Discuss approaches to increase COVID-19 vaccine uptake, with a focus on the role of healthcare workers
    COVID-19, Vaccines, Viral Infections, Respiratory Infections
    Watch Time: 40 mins
    touchIN CONVERSATION
    Practical considerations for COVID-19 vaccination in Africa
    CE/CME ACCREDITED Dr Christina Obiero, Dr John Amuasi Translations available:

    Watch experts in infectious diseases discuss COVID-19 vaccination challenges and strategies for improving vaccine uptake in Africa.

    Learning objectives
    Learning Objectives
    • Outline the benefits and risks associated with COVID-19 vaccines
    • Identify reasons for low COVID-19 vaccine uptake in Africa
    • Discuss approaches to increase COVID-19 vaccine uptake, with a focus on the role of healthcare workers
    COVID-19, Vaccines, Viral Infections, Respiratory Infections
    Watch Time: 59 mins
    touchPANEL DISCUSSION
    Reducing transmission of COVID-19: Spotlight on vaccines
    CE/CME ACCREDITED Dr Angus Thomson, Dr Amaya Gillespie, Dr Henry Kyobe Bosa Translations available:

    A series of expert panel discussions providing multiple perspectives on a selection of key topics and what the data may mean for clinical practice

    Learning objectives
    Learning Objectives
    • Summarize the current COVID-19 vaccination landscape
    • Identify factors contributing to differential uptake of COVID-19 vaccines in population subsets
    • Evaluate strategies to improve COVID-19 vaccine uptake
    • Discuss the future of COVID-19 vaccination, including how vaccine inequity may be addressed
    Respiratory Infections, Fungal Infections
    Developed by Touch
    Chronic pulmonary aspergillosis, an update on diagnosis and treatment: David Denning, ECCMID 2023
    Watch Time: 6 mins

    Chronic pulmonary aspergillosis (CPA) is a complicated respiratory disease associated with high morbidity and mortality rates. This overlooked disease often comes with delayed diagnosis and treatment, demonstrating a need for increased awareness and education in this area. We met with Prof. David Denning (The University of Manchester, Manchester, United Kingdom) to discuss the current state […]

    Respiratory Infections
    Uniting to end the TB epidemic: World TB Day 2023

    World Tuberculosis (TB) Day is observed annually on 24 March to raise awareness about tuberculosis and to commemorate the discovery of the Mycobacterium tuberculosis bacterium (M.tb) by Dr Robert Koch in 1882. It aims to educate people about the impact of TB on public health, and encourage governments and organizations to take action towards ending the TB […]

    Respiratory Infections
    Isolated Tuberculosis of the Ribs in an Immunocompetent Adult
    Venkatraman Rajkumar

    touchREVIEWS in Infectious Diseases. 2022;1(1):39-43 DOI: https://doi.org/10.17925/ID.2022.1.1.39

    Extrapulmonary tuberculosis (TB) – i.e. when the disease presents outside of the lungs – has existed since antiquity, as evidenced by studies in paleopathology.1 The skeleton is a common site for extrapulmonary TB, but isolated rib TB is rare.2 One in 50 patients with musculoskeletal TB will have rib involvement.2–4 Extrapulmonary TB is more common in areas […]

    Copied to clipboard!
    accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72